Yesterday, startup LifePlus exited stealth mode to reveal what it claims to be the first noninvasive continuous blood glucose monitoring multi-sensor wearable, called LifeLeaf. Although details are scare on exactly how the technology works, the company said the product is being tested in five clinical trials around the world.
from MobiHealthNews https://ift.tt/2wT0K3I
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment